Jose Luis Gonzalez-Larriba
Overview
Explore the profile of Jose Luis Gonzalez-Larriba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calvo V, Niazmand E, Carcereny E, Rodriguez-Abreu D, Cobo M, Lopez-Castro R, et al.
Lung Cancer
. 2024 Aug;
195:107920.
PMID: 39137596
Objectives: Lung Cancer (LC) is a multifactorial disease for which the role of genetic susceptibility has become increasingly relevant. Our aim was to use artificial intelligence (AI) to analyze differences...
2.
Provencio M, Robado de Lope L, Serna-Blasco R, Nadal E, Diz Tain P, Massuti B, et al.
Lung Cancer
. 2024 Jun;
194:107865.
PMID: 38945004
Background: Immunotherapy-based treatments have demonstrated high efficacy in patients with advanced and locally advanced non-small-cell lung cancer (NSCLC). BRAF mutations affect a small but significant fraction of NSCLC. The efficacy...
3.
Gutierrez L, Royuela A, Carcereny E, Lopez-Castro R, Rodriguez-Abreu D, Massuti B, et al.
BMC Cancer
. 2021 Sep;
21(1):977.
PMID: 34465283
Background: There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC patients with long-term survival. This study develops a prognostic model using real world data to assist...
4.
Garrido P, Paz-Ares L, Majem M, Moran T, Trigo J, Bosch-Barrera J, et al.
Cancer Med
. 2021 Jul;
10(17):5878-5888.
PMID: 34296539
Objectives: The aim of LungBEAM was to determine the value of a novel epidermal growth factor receptor (EGFR) mutation test in blood based on BEAMing technology to predict disease progression...
5.
Vinolas N, Garcia-Campelo R, Majem M, Carcereny E, Isla D, Luis Gonzalez-Larriba J, et al.
BMC Psychol
. 2020 Nov;
8(1):123.
PMID: 33228796
Background: Little is known about the impact of sex on lung cancer patients from the psychological, economic and social perspectives. This study was designed to explore the psychosocial and economic...
6.
Rodriguez-Vida A, Bamias A, Esteban E, Saez M, Lopez-Brea M, Castellano D, et al.
BJU Int
. 2020 Jul;
126(5):559-567.
PMID: 32654362
Objective: To investigate the efficacy of alternating cycles of sunitinib and everolimus vs standard sequential treatment of sunitinib followed by everolimus in first-line metastatic renal cell carcinoma (mRCC), as alternating...
7.
Barquin M, Calvo V, Garcia-Garcia F, Nunez B, Sanchez-Herrero E, Serna-Blasco R, et al.
Cancer Epidemiol
. 2020 May;
67:101737.
PMID: 32450544
Background: Biological differences between the sexes have a major impact on disease and treatment outcome. In this paper, we evaluate the prognostic value of sex in stage IV non-small-cell lung...
8.
Provencio M, Carcereny E, Rodriguez-Abreu D, Lopez-Castro R, Guirado M, Camps C, et al.
Transl Lung Cancer Res
. 2019 Sep;
8(4):461-475.
PMID: 31555519
Background: Lung cancer remains a leading cause of cancer incidence and mortality worldwide. Although Spain contributes to global statistics related to cancer, it is difficult to discern aspects linked to...
9.
Conde E, Hernandez S, Martinez R, Angulo B, de Castro J, Collazo-Lorduy A, et al.
J Thorac Oncol
. 2019 Jul;
14(12):2120-2132.
PMID: 31349061
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support...
10.
Zugazagoitia J, Biosca M, Oliveira J, Olmedo M, Domine M, Nadal E, et al.
Eur Respir J
. 2018 Mar;
51(5).
PMID: 29563169
No abstract available.